back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-30 21:55 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,480
+64,000 vol $0.07 each |
214,000 | |
| Filed 2025-12-30 21:54 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+20,000 vol $0.065 each |
250,000 | |
| Filed 2025-12-30 21:53 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$960.00
+16,000 vol $0.06 each |
230,000 | |
| Filed 2025-12-30 21:52 Tx date 2022-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,820
+26,000 vol $0.07 each |
150,000 | |
| Filed 2025-12-30 21:51 Tx date 2022-07-21 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$280.00
+4,000 vol $0.07 each |
124,000 | |
| Filed 2025-12-30 21:50 Tx date 2022-07-20 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,400
+120,000 vol $0.07 each |
120,000 | |
| Filed 2022-08-26 19:49 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+20,000 vol $0.065 each |
||
| Filed 2022-08-26 19:48 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$960.00
+16,000 vol $0.06 each |
||
| Filed 2022-08-26 19:46 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,480
+64,000 vol $0.07 each |
||
| Filed 2022-08-26 19:45 Tx date 2022-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,820
+26,000 vol $0.07 each |
||
| Filed 2022-08-26 19:44 Tx date 2022-07-21 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$280.00
+4,000 vol $0.07 each |
||
| Filed 2022-08-26 19:43 Tx date 2022-07-20 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,400
+120,000 vol $0.07 each |
||
| Filed 2025-10-21 21:21 Tx date 2024-04-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,350
+490,000 vol $0.015 each |
1,355,000 | |
| Filed 2025-10-21 21:20 Tx date 2024-03-04 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,820
+391,000 vol $0.02 each |
865,000 | |
| Filed 2025-10-21 21:19 Tx date 2024-03-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15.00
+1,000 vol $0.015 each |
474,000 | |
| Filed 2025-10-21 21:18 Tx date 2024-02-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,620
+108,000 vol $0.015 each |
473,000 | |
| Filed 2025-10-21 21:17 Tx date 2023-10-30 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+100,000 vol $0.0325 each |
365,000 | |
| Filed 2025-10-21 21:15 Tx date 2022-12-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,625
+265,000 vol $0.025 each |
265,000 | |
| Filed 2025-10-21 21:14 Tx date 2021-02-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-21 21:13 Tx date 2022-11-21 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,640
+88,000 vol $0.03 each |
7,016,666 |